title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,SELB,0.00644,Neutral,-0.006385
Stocks That Hit 52-Week Lows On Monday,20220418T154044,https://www.benzinga.com/news/22/04/26669813/stocks-that-hit-52-week-lows-on-monday,SELB,0.005428,Neutral,-0.001126
Stocks That Hit 52-Week Lows On Tuesday,20220315T163235,https://www.benzinga.com/news/22/03/26148458/stocks-that-hit-52-week-lows-on-tuesday,SELB,0.00539,Neutral,-0.003321
Stocks That Hit 52-Week Lows On Wednesday,20220427T184104,https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article,SELB,0.006956,Neutral,-0.000284
Stocks That Hit 52-Week Lows On Wednesday,20220504T162909,https://www.benzinga.com/markets/options/22/05/26995541/52-weeks-high-and-low-article,SELB,0.012359,Neutral,-0.001416
Stocks That Hit 52-Week Lows On Friday,20220422T162629,https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article,SELB,0.012589,Neutral,-0.001529
Selecta Biosciences  ( NASDAQ:SELB )  Rating Lowered to Hold at StockNews.com,20230609T052849,https://www.defenseworld.net/2023/06/09/selecta-biosciences-nasdaqselb-rating-lowered-to-hold-at-stocknews-com.html,SELB,0.917988,Bullish,0.391981
"Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket - First Majestic Silver  ( NYSE:AG ) , Allarity Therapeutics  ( NASDAQ:ALLR ) ",20230321T121144,https://www.benzinga.com/news/23/03/31436513/why-cerberus-cyber-sentinel-shares-are-trading-higher-by-147-here-are-20-stocks-moving-premarket,SELB,0.207571,Neutral,0.01167
"Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate",20220804T130628,https://www.benzinga.com/general/biotech/22/08/28353376/biotech-daily-amgen-gilead-go-shopping-nod-for-astrazenecas-lynparza-in-early-stage-breast-cancer,SELB,0.09989,Neutral,0.0
